Medical Research Laboratories International Report issue

For profit Phase 2
Founded: Cincinnati OH United States (1988)
Status: Acquired by PPD (2003) → now Thermo Fisher Scientific (2021)

Organization Overview

First Clinical Trial
2003
NCT00079846
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

implitapide (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Hyperlipoproteinemia Type II (Phase 2)

Hypertriglyceridemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1